Immunogenicity and protective efficacy of recombinant Clostridium difficile flagellar protein FliC

Emerging Microbes and Infections

Volumn 5, Issue , 2016, Pages

  Ghose, Chandrabali ^a   Eugenis, Ioannis ^a   Sun, Xingmin ^b   Edwards, Adrianne N ^c   McBride, Shonna M ^c   Pride, David T ^d   Kelly, Ciarán P ^e   Ho, David D ^a,f  

^a AARON DIAMOND AIDS RESEARCH CENTER   (United States)

^b TUFTS UNIVERSITY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; FLAGELLIN; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN G; BACTERIAL VACCINE; BACTERIUM ANTIBODY; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CLOSTRIDIUM DIFFICILE INFECTION; COLITIS; COMPARATIVE STUDY; CONTROLLED STUDY; DEATH; DIARRHEA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HAMSTER; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; MALE; MICROBIOME; MOLECULAR CLONING; MORBIDITY; MOUSE; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RECEPTOR BINDING; VACCINATION; WEIGHT REDUCTION; WESTERN BLOTTING; ANIMAL; BLOOD; C57BL MOUSE; CHEMISTRY; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; CYTOLOGY; DISEASE MODEL; FECES; FLAGELLUM; GENETICS; HUMAN; IMMUNOLOGY; INTESTINE FLORA; MICROBIOLOGY; PASSIVE IMMUNIZATION;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CRICETINAE; CROSS INFECTION; DISEASE MODELS, ANIMAL; FECES; FEMALE; FLAGELLA; FLAGELLIN; GASTROINTESTINAL MICROBIOME; HUMANS; IMMUNIZATION; IMMUNIZATION, PASSIVE; MICE; MICE, INBRED C57BL; RECOMBINANT PROTEINS;

EID: 84957588569     PISSN: None     EISSN: 22221751     Source Type: Journal    
DOI: 10.1038/emi.2016.10     Document Type: Article

References (70)

1. Kelly CP, LaMont JT. Clostridium difficile-more difficult than ever. N Engl J Med 2008; 359: 1932-1940.
2. Bartlett JG. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med 2006; 145: 758-764.
3. Baban ST, Kuehne SA, Barketi-Klai A et al. The role of flagella in Clostridium difficile pathogenesis: comparison between a non-epidemic and an epidemic strain. PLoS One 2013; 8: e73026.
4. Kelly CP. Immune response to Clostridium difficile infection. Eur J Gastroenterol Hepatol 1996; 8: 1048-1053.
5. Kyne L, Warny M, Qamar A et al. Natural immunity against Clostridium difficile toxin A protects against diarrhea and pseudomembranous colitis. Gastroenterol 1999; 116: A895-A895.
6. Kyne L, Warny M, Qamar A et al. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 2000; 342: 390-397.
7. Ghose C, Kelly CP. The prospect for vaccines to prevent Clostridium difficile infection. Infect Dis Clin North Am 2015; 29: 145-162.
8. Kim PH, Iaconis JP, Rolfe RD. Immunization of adult hamsters against Clostridium difficile-associated ileocecitis and transfer of protection to infant hamsters. Infect Immun 1987; 55: 2984-2992.
9. Mulligan ME, Miller SD, McFarland LV, Fung HC, Kwok RY. Elevated levels of serum immunoglobulins in asymptomatic carriers of Clostridium difficile. Clin Infect Dis 1993; 16 Suppl 4: S239-S244.
10. Pechine S, Janoir C, Boureau H et al. Diminished intestinal colonization by Clostridium difficile and immune response in mice after mucosal immunization with surface proteins of Clostridium difficile. Vaccine 2007; 25: 3946-3954.
11. Pechine S, Janoir C, Collignon A. Variability of Clostridium difficile surface proteins and specific serum antibody response in patients with Clostridium difficile-associated disease. J Clin Microbiol 2005; 43: 5018-5025.
12. Pechine S, Gleizes A, Janoir C et al. Immunological properties of surface proteins of Clostridium difficile. J Med Microbiol 2005; 54: 193-196.
13. Tasteyre A, Barc MC, Collignon A, Boureau H, Karjalainen T. Role of FliC and FliD flagellar proteins of Clostridium difficile in adherence and gut colonization. Infect Immun 2001; 69: 7937-7940.
14. Aubry A, Hussack G, Chen W et al. Modulation of toxin production by the flagellar regulon in Clostridium difficile. Infect Immun 2012; 80: 3521-3532.
15. Dapa T, Unnikrishnan M. Biofilm formation by Clostridium difficile. Gut Microbes 2013; 4: 397-402.
16. Tasteyre A, Barc MC, Karjalainen T et al. A Clostridium difficile gene encoding flagellin. Microbiol 2000; 146: 957-966.
17. Tasteyre A, Karjalainen T, Avesani V et al. Phenotypic and genotypic diversity of the flagellin gene (fliC) among Clostridium difficile isolates from different serogroups. J Clin Microbiol 2000; 38: 3179-3186.
18. Tasteyre A, Karjalainen T, Avesani V et al. Molecular characterization of fliD gene encoding flagellar cap and its expression among Clostridium difficile isolates from different serogroups. J Clin Microbiol 2001; 39: 1178-1183.
19. Anderson JK, Smith TG, Hoover TR. Sense and sensibility: flagellum-mediated gene regulation. Trends Microbiol 2010; 18: 30-37.
20. Pituch H, Obuch-Woszczatynski P, van den Braak N et al. Variable flagella expression among clonal toxin A(-)/B1 Clostridium difficile strains with highly homogeneous flagellin genes. Clin Microbiol Infect 2002; 8: 187-188.
21. Ghose C, Verhagen JM, Chen X et al. Toll-like receptor 5-dependent immunogenicity and protective efficacy of a recombinant fusion protein vaccine containing the nontoxic domains of Clostridium difficile toxins A and B and Salmonella enterica serovar typhimurium flagellin in a mouse model of Clostridium difficile disease. Infect Immun 2013; 81: 2190-2196.
22. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2: 675-680.
23. Price GA, Holmes RK. Immunizing adult female mice with a TcpA-A2-CTB chimera provides a high level of protection for their pups in the infant mouse model of cholera. PLoS Negl Trop Dis 2014; 8: e3356.
24. van Duin D, Medzhitov R, Shaw AC. Triggering TLR signaling in vaccination. Trends Immunol 2006; 27: 49-55.
25. Leal MT, Camacho AG, Teixeira LH et al. Immunogenicity of recombinant proteins consisting of Plasmodium vivax circumsporozoite protein allelic variant-derived epitopes fused with Salmonella enterica Serovar Typhimurium flagellin. Clin Vaccine Immunol 2013; 20: 1418-1425.
26. Jarchum I, Liu M, Lipuma L, Pamer EG. Toll-like receptor 5 stimulation protects mice from acute Clostridium difficile colitis. Infect Immun 2011; 79: 1498-1503.
27. Killgore G, Thompson A, Johnson S et al. Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing. J Clin Microbiol 2008; 46: 431-437.
28. Hussain HA, Roberts AP, Mullany P. Generation of an erythromycin-sensitive derivative of Clostridium difficile strain 630 (630Deltaerm) and demonstration that the conjugative transposon Tn916DeltaE enters the genome of this strain at multiple sites. J Med Microbiol 2005; 54: 137-141.
29. Sebaihia M, Wren BW, Mullany P et al. The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat Genet 2006; 38: 779-786.
30. Mullany P, Wilks M, Tabaqchali S. Transfer of macrolide-lincosamide-streptograminB (MLS) resistance in Clostridium difficile is linked to a gene homologous with toxin A and is mediated by a conjugative transposon, Tn5398. J Antimicrob Chemother 1995; 35: 305-315.
31. Edwards AN, Nawrocki KL, McBride SM. Conserved oligopeptide permeases modulate sporulation initiation in Clostridium difficile. Infect Immun 2014; 82: 4276-4291.
32. Sun X, Wang H, Zhang Y et al. Mouse relapse model of Clostridium difficile infection. Infect Immun 2011; 79: 2856-2864.
33. Edwards AN, Suarez JM, McBride SM. Culturing and maintaining Clostridium difficile in an anaerobic environment. J Vis Exp 2013; 79: e50787.
34. Zhao X, Li G, Liang S. Several affinity tags commonly used in chromatographic purification. J Anal Methods Chem 2013; 2013: 581093.
35. Loughran ST, Walls D. Purification of poly-histidine-tagged proteins. Methods Mol Biol 2011; 681: 311-335.
36. Ghose C, Kalsy A, Sheikh A et al. Transcutaneous immunization with Clostridium difficile toxoid A induces systemic and mucosal immune responses and toxin Aneutralizing antibodies in mice. Infect Immun 2007; 75: 2826-2832.
37. Kragstrup TW, Vorup-Jensen T, Deleuran B, Hvid M. A simple set of validation steps identifies and removes false results in a sandwich enzyme-linked immunosorbent assay caused by anti-animal IgG antibodies in plasma from arthritis patients. Springer Plus 2013; 2: 263.
38. Hancock K, Tsang VC. Development and optimization of the FAST-ELISA for detecting antibodies to Schistosoma mansoni. J Immunol Methods 1986; 92: 167-176.
39. Snyder MH, Banks S, Murphy BR. Determination of antibody response to influenza virus surface glycoproteins by kinetic enzyme-linked immunosorbent assay. J Clin Microbiol 1988; 26: 2034-2040.
40. Lawley TD, Clare S, Walker AW et al. Antibiotic treatment of Clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts. Infect Immun 2009; 77: 3661-3669.
41. Whiteley AS, Jenkins S, Waite I et al. Microbial 16S rRNA Ion Tag and community metagenome sequencing using the Ion Torrent (PGM) Platform. J Microbiol Methods 2012; 91: 80-88.
42. Rothberg JM, Hinz W, Rearick TM et al. An integrated semiconductor device enabling non-optical genome sequencing. Nature 2011; 475: 348-352.
43. Caporaso JG, Kuczynski J, Stombaugh J et al. QIIME allows analysis of highthroughput community sequencing data. Nat Methods 2010; 7: 335-336.
44. Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 2010; 26: 2460-2461.
45. Caporaso JG, Bittinger K, Bushman FD et al. PyNAST: a flexible tool for aligning sequences to a template alignment. Bioinformatics 2010; 26: 266-267.
46. DeSantis TZ, Hugenholtz P, LarsenNet al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol 2006; 72: 5069-5072.
47. Li W, Godzik A. Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinformatics 2006; 22: 1658-1659.
48. Price MN, Dehal PS, Arkin AP. FastTree: computing large minimum evolution trees with profiles instead of a distance matrix. Mol Biol Evol 2009; 26: 1641-1650.
49. Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol 2007; 73: 5261-5267.
50. Lozupone C, Hamady M, Knight R. UniFrac-an online tool for comparing microbial community diversity in a phylogenetic context. BMC Bioinformatics 2006; 7: 371.
51. Costa S, Almeida A, Castro A, Domingues L. Fusion tags for protein solubility, purification and immunogenicity in Escherichia coli: the novel Fh8 system. Front Microbiol 2014; 5: 63.
52. Skene C, Young A, Every A, Sutton P. Helicobacter pylori flagella: antigenic profile and protective immunity. Fems Immunol Med Microbiol 2007; 50: 249-256.
53. Ethapa T, Leuzzi R, Ng YK et al. Multiple factors modulate biofilm formation by the anaerobic pathogen Clostridium difficile. J Bacteriol 2012; 195: 545-555.
54. Zhao S, Ghose-Paul C, Zhang K, Tzipori S, Sun X. Immune-based treatment and prevention of Clostridium difficile infection. Hum Vaccin Immunother 2014; 10: 3522-3530.
55. Andersen-Nissen E, Smith KD, Strobe KL et al. Evasion of Toll-like receptor 5 by flagellated bacteria. Proc Natl Acad Sci USA 2005; 102: 9247-9252.
56. Brun P, Scarpa M, Grillo A et al. Clostridium difficile TxAC314 and SLP-36kDa enhance the immune response toward a co-administered antigen. J Med Microbiol 2008; 57: 725-731.
57. Chen X, Katchar K, Goldsmith JD et al. A mouse model of Clostridium difficileassociated disease. Gastroenterol 2008; 135: 1984-1992.
58. Brandtzaeg P. Induction of secretory immunity and memory at mucosal surfaces. Vaccine 2007; 25: 5467-5484.
59. Israel EJ, Taylor S, Wu Z et al. Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells. Immunology 1997; 92: 69-74.
60. Zhang Z, Chen X, Hernandez LD et al. Toxin-mediated paracellular transport of antitoxin antibodies facilitates protection against Clostridium difficile infection. Infect Immun 2015; 83: 405-416.
61. Kyne L, Warny M, Qamar A, Kelly CP. High anti-toxin A antibody levels are associated with protection against recurrent Clostridium difficile diarrhea. Gastroenterol 2000; 118: A885-A885.
62. Kyne L, Warny M, Qamar A, Kelly CP. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet 2001; 357: 189-193.
63. Wada N, Nishida N, Iwaki S et al.Neutralizing activity against Clostridiumdifficile toxin in the supernatants of cultured colostral cells. Infect Immun 1980; 29: 545-550.
64. Kuehne SA, Cartman ST, Heap JT et al. The role of toxin A and toxin B in Clostridium difficile infection. Nature 2010; 467: 711-713.
65. Pechine S, Deneve C, Le Monnier A et al. Immunization of hamsters against Clostridium difficile infection using the Cwp84 protease as an antigen. FEMS Immunol Med Microbiol 2011; 63: 73-81.
66. Ni Eidhin DB, O'Brien JB, McCabe MS, Athie-Morales V, Kelleher DP. Active immunization of hamsters against Clostridium difficile infection using surface-layer protein. FEMS Immunol Med Microbiol 2008; 52: 207-218.
67. Cullender TC, Chassaing B, Janzon A et al. Innate and adaptive immunity interact to quench microbiome flagellarmotility in the gut. CellHost Microbe 2013; 14: 571-581.
68. Solomon K. The host immune response to Clostridium difficile infection. Ther Adv Infect Dis 2013; 1: 19-35.
69. McKee RW, Mangalea MR, Purcell EB, Borchardt EK, Tamayo R. The second messenger cyclic Di-GMP regulates Clostridium difficile toxin production by controlling expression of sigD. J Bacteriol 2013; 195: 5174-5185.
70. Barketi-Klai A,MonotM, Hoys S et al. The flagellin FliC of Clostridium difficile is responsible for pleiotropic gene regulation during in vivo infection. PLoS One 2014; 9: e96876.